BD will issue a press release detailing the quarter's results, along with related presentation materials posted to www.bd.com/investors, at approximately 6:00 a.m. Eastern Time (ET).
In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).
The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2021 financial and operating results.
Medtronic today announced its ongoing commitment to health equity for people of color living with diabetes. The company committed investments in partnerships with the American Diabetes Association and T1D Exchange, as well as additional research efforts, to better understand and address these disparities.
#institution
Liva Healthcare, a European market leader in scalable digital health coaching, has announced its participation in a new partnership collaboration initiative to make cardiac rehabilitation accessible to more patients in the immediate aftermath of a heart attack. The European Institute of Innovation and Technology (EIT) Health recently announced that Rehab+ has won a prestigious Education Award, which enables Rehab+ to be implemented in four rehabilitation centres across Spain and the Netherlands and evaluated by Maastricht University (Center for Cardiology Research). Based on the scientific evaluation, further uptake of Rehab+ in Netherlands, Spain and additional countries will be discussed. To develop Rehab+, Amgen collaborated with Liva Healthcare, rehabilitation hospitals in Spain, La Paz in Madrid, Vall d’Hebron in Barcelona, Virgen de la Victoria in Malaga and Zuyderland in the Netherlands.
#r&d
#coaching
Omada Health, one of the U.S.’s original virtual healthcare providers, today announced the creation of the Omada Insights Lab.
Nemaura Medical, Inc., a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced the launch of its BEAT®diabetes app on the GooglePlay and iOS platforms
#mobile app
Medtronic , the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first and only infusion set that can be worn for up to 7 days. An infusion set is tubing that delivers insulin from the pump to the body and typically requires a set change every few days.
#insulin pump
People with impaired awareness of hypoglycemia (IAH) are at elevated risk of severe, potentially hazardous, hypoglycemia and would benefit from a device alerting to hypoglycemia. Heart rate variability (HRV) changes with hypoglycemia due to sympathetic activity. Since IAH is associated with suppressed sympathetic activity, we investigated whether hypoglycemia elicits a measurable change in HRV in patients with T1D and IAH.
#cgm
The algorithm for the Dexcom G6 CGM System was enhanced to retain accuracy while reducing the frequency and duration of sensor error. The new algorithm was evaluated by post-processing raw signals collected from G6 pivotal trials (NCT02880267) and by assessing the difference in data availability after a limited, real-world launch.
#cgm